Roundhill GLP-1 & Weight Loss ETF (OZEM)

NASDAQ: OZEM · Real-Time Price · USD
25.45
-0.12 (-0.47%)
Nov 21, 2024, 10:33 AM EST - Market open
-0.47%
Assets $40.44M
Expense Ratio 0.59%
PE Ratio 28.61
Shares Out 1.63M
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return n/a
Volume 4,119
Open 25.45
Previous Close 25.57
Day's Range 25.22 - 25.45
52-Week Low 24.51
52-Week High 29.21
Beta n/a
Holdings n/a
Inception Date May 21, 2024

About OZEM

Fund Home Page

The Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management. OZEM was launched on May 21, 2024 and is issued by Roundhill.

Asset Class Equity
Category Health
Stock Exchange NASDAQ
Ticker Symbol OZEM
ETF Provider Roundhill

News

Disruptive Theme of the Week: Happy Post-Election Themes

With the completion of a close presidential election, roughly half of us are likely disappointed regardless of the winner. To counter the post-election blues, I identified some “happy” ETF themes to c...

12 days ago - ETF Trends

Mag7, AI and GLP-1: Roundhill CEO on the hottest ETFs to watch

Dave Mazza, Roundhill Investments CEO, joins CNBC's Bob Pisani on “Halftime Report's” “ETF Edge” segment to discuss the firms' three ETFs following the Mag7, AI and GLP-1 themes.

Other symbols: CHATMAGS
2 months ago - CNBC Television

Why Investors Haven't Feasted on Two New Weight-Loss ETFs

Two new weight-loss exchange-traded funds (ETFs) launched in May have yet to whet investors' appetite, possibly due to their expensive fees and concentrated bets.

Other symbols: THNR
5 months ago - Investopedia

OZEM: Investing in the Weight Loss Craze

Roundhill Investments launched its GLP-1 and Weight Loss ETF (OZEM) on May 21st. Dave Mazza discusses investing in the weight loss craze.

6 months ago - Schwab Network

This new weight loss drug ETF bets big on two of the industry's leading players

While Novo Nordisk and Eli Lilly have soared in the past year, Roundhill Investments sees bigger gains ahead for the GLP-1 drugmakers.

6 months ago - CNBC

New funds jump on weight loss trade

6 months ago - CNBC Television

Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)

OZEM provides exposure to the rapidly growing weight loss management market, which is expected to reach $100 billion by 2030. NEW YORK , May 21, 2024 /PRNewswire/ -- Roundhill Investments, an ETF spon...

6 months ago - PRNewsWire

Roundhill to launch active weight loss ETF

Dave Mazza, Roundhill Investments CEO, sits down with CNBC's Bob Pisani to discuss the firm's new weight loss ETF (OZEM). They dig into the ETF's holdings, why it's actively managed and more.

6 months ago - CNBC Television